Bulk Manufacturer of Controlled Substances Application: AMPAC Fine Chemicals, LLC, 40874 [2021-16137]
Download as PDF
<![CDATA[
40874
Federal Register / Vol. 86, No. 143 / Thursday, July 29, 2021 / Notices
The company plans to bulk
manufacture the listed controlled
substances for distribution to its
customers.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–869]
Bulk Manufacturer of Controlled
Substances Application: AMPAC Fine
Chemicals, LLC
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021–16137 Filed 7–28–21; 8:45 am]
BILLING CODE P
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
DEPARTMENT OF JUSTICE
AMPAC Fine Chemicals, LLC.
has applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
Supplemental Information listed below
for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before September 27, 2021. Such
persons may also file a written request
for a hearing on the application on or
before September 27, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on June 14, 2021, AMPAC
Fine Chemicals, LLC., Highway 50 and
Hazel Avenue, Rancho Cordova,
California 95670, applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substance(s):
SUMMARY:
Controlled substance
Norlevorphanol ...............
Methylphenidate .............
Levomethorphan .............
Levorphanol ....................
Thebaine .........................
Remifentanil ....................
Tapentadol ......................
Drug
code
Schedule
9634
1724
9210
9220
9333
9739
9780
I
II
II
II
II
II
II
Drug Enforcement Administration
[Docket No. DEA–870]
Bulk Manufacturer of Controlled
Substances Application: Bulk
Manufacturer of Marihuana: Nusachi
Labs, LLC.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
The Drug Enforcement
Administration (DEA) is providing
notice of an application it has received
from an entity applying to be registered
to manufacture in bulk basic class(es) of
controlled substances listed in schedule
I. DEA intends to evaluate this and other
pending applications according to its
regulations governing the program of
growing marihuana for scientific and
medical research under DEA
registration.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefor, may file written
comments on or objections to the
issuance of the proposed registration on
or before September 27, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW 8701
Morrissette Drive, Springfield, Virginia
22152. To ensure proper handling of
comments, please reference Docket
No—DEA–870 in all correspondence,
including attachments.
SUPPLEMENTARY INFORMATION: The
Controlled Substances Act (CSA)
SUMMARY:
prohibits the cultivation and
distribution of marihuana except by
persons who are registered under the
CSA to do so for lawful purposes. In
accordance with the purposes specified
in 21 CFR 1301.33(a), DEA is providing
notice that the entity identified below
has applied for registration as a bulk
manufacturer of schedule I controlled
substances. In response, registered bulk
manufacturers of the affected basic
class(es), and applicants therefor, may
file written comments on or objections
of the requested registration, as
provided in this notice. This notice does
not constitute any evaluation or
determination of the merits of the
application submitted.
The applicant plans to manufacture
bulk active pharmaceutical ingredients
(APIs) for product development and
distribution to DEA-registered
researchers. If the application for
registration is granted, the registrant
would not be authorized to conduct
other activity under this registration
aside from those coincident activities
specifically authorized by DEA
regulations. DEA will evaluate the
application for registration as a bulk
manufacturer for compliance with all
applicable laws, treaties, and
regulations and to ensure adequate
safeguards against diversion are in
place.
As this applicant has applied to
become registered as a bulk
manufacturer of marihuana, the
application will be evaluated under the
criteria of 21 U.S.C. 823(a). DEA will
conduct this evaluation in the manner
described in the rule published at 85 FR
82333 on December 18, 2020, and
reflected in DEA regulations at 21 CFR
part 1318.
In accordance with 21 CFR
1301.33(a), DEA is providing notice that
on June 23, 2021, Nusachi Labs, LLC.,
2909 Armory Drive, Nashville,
Tennessee 37204, applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substances:
Controlled substance
Drug code
jbell on DSKJLSW7X2PROD with NOTICES
Marihuana ................................................................................................................................................................
Tetrahydrocannabinols ............................................................................................................................................
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021–16141 Filed 7–28–21; 8:45 am]
BILLING CODE P
VerDate Sep<11>2014
19:19 Jul 28, 2021
Jkt 253001
PO 00000
Frm 00073
Fmt 4703
Sfmt 9990
E:\FR\FM\29JYN1.SGM
29JYN1
7360
7370
Schedule
I
I
]]>Agencies
[Federal Register Volume 86, Number 143 (Thursday, July 29, 2021)]
[Notices]
[Page 40874]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-16137]
[[Page 40874]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-869]
Bulk Manufacturer of Controlled Substances Application: AMPAC
Fine Chemicals, LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: AMPAC Fine Chemicals, LLC. has applied to be registered as a
bulk manufacturer of basic class(es) of controlled substance(s). Refer
to Supplemental Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before September 27,
2021. Such persons may also file a written request for a hearing on the
application on or before September 27, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on June 14, 2021, AMPAC Fine Chemicals, LLC., Highway 50
and Hazel Avenue, Rancho Cordova, California 95670, applied to be
registered as a bulk manufacturer of the following basic class(es) of
controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Norlevorphanol......................... 9634 I
Methylphenidate........................ 1724 II
Levomethorphan......................... 9210 II
Levorphanol............................ 9220 II
Thebaine............................... 9333 II
Remifentanil........................... 9739 II
Tapentadol............................. 9780 II
------------------------------------------------------------------------
The company plans to bulk manufacture the listed controlled
substances for distribution to its customers.
Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021-16137 Filed 7-28-21; 8:45 am]
BILLING CODE P
